Furthermore, PACS-2 deficiency accelerated the progression of diabetic kidney function and disruption of MAM interfaces, whereas adenoviral PACS-2 overexpression alleviated diabetes- and HG- associated ER stress, mitochondrial dysfunction, and renal tubular apoptosis and fibrosis. This evidence concerns the gene PACS2 and diabetes mellitus.